Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies.

Jianfeng XuW Kyle ResurreccionZhuqing ShiJun WeiChi-Hsiung WangS Lilly ZhengPeter J HulickAshley E RossChristian P PavlovichBrian T HelfandWilliam B Isaacs

Published in: Prostate cancer and prostatic diseases (2022)

The complementary performance of three inherited risk measures in PCa risk stratification is consistently supported. Their clinical utility in predicting PCa detection rate, if confirmed in prospective clinical trials, may improve current decision-making for prostate biopsy.

Keyphrases

prostate cancer
risk assessment
clinical trial
decision making
radical prostatectomy
ultrasound guided
benign prostatic hyperplasia
human health
heavy metals
fine needle aspiration
randomized controlled trial
real time pcr
open label
climate change
quantum dots
sensitive detection
placebo controlled